- Home
- PHVS vs AMSC Comparison
PHVS vs AMSC Comparison
Compare PHVS & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- AMSC
- Stock Information
- Founded
- PHVS 2015
- AMSC 1987
- Country
- PHVS Switzerland
- AMSC United States
- Employees
- PHVS N/A
- AMSC N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- AMSC Metal Fabrications
- Sector
- PHVS Health Care
- AMSC Consumer Discretionary
- Exchange
- PHVS Nasdaq
- AMSC Nasdaq
- Market Cap
- PHVS 1.3B
- AMSC 2.6B
- IPO Year
- PHVS 2021
- AMSC 1991
- Fundamental
- Price
- PHVS $24.08
- AMSC $60.49
- Analyst Decision
- PHVS Strong Buy
- AMSC Strong Buy
- Analyst Count
- PHVS 5
- AMSC 2
- Target Price
- PHVS $35.60
- AMSC $34.00
- AVG Volume (30 Days)
- PHVS 123.2K
- AMSC 927.0K
- Earning Date
- PHVS 11-12-2025
- AMSC 10-29-2025
- Dividend Yield
- PHVS N/A
- AMSC N/A
- EPS Growth
- PHVS N/A
- AMSC N/A
- EPS
- PHVS N/A
- AMSC 0.39
- Revenue
- PHVS N/A
- AMSC $254,886,000.00
- Revenue This Year
- PHVS N/A
- AMSC $28.23
- Revenue Next Year
- PHVS N/A
- AMSC $11.78
- P/E Ratio
- PHVS N/A
- AMSC $153.16
- Revenue Growth
- PHVS N/A
- AMSC 63.73
- 52 Week Low
- PHVS $11.51
- AMSC $13.98
- 52 Week High
- PHVS $26.33
- AMSC $61.00
- Technical
- Relative Strength Index (RSI)
- PHVS 58.67
- AMSC 72.13
- Support Level
- PHVS $23.20
- AMSC $54.89
- Resistance Level
- PHVS $24.02
- AMSC $57.30
- Average True Range (ATR)
- PHVS 1.37
- AMSC 2.82
- MACD
- PHVS 0.04
- AMSC 0.77
- Stochastic Oscillator
- PHVS 78.51
- AMSC 95.77
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.